ASCEND
BY NTHRYS

NTHRYSPhD AssistanceHematology

Hematology

Field
Category

Hematology

Select a category to explore research frontiers

Hematology200 categories·80 research gap frontiers·access £41
UIRG Unique Individual Research GapFrontier Research Gap Frontier, groups 3+ UIRGsChip badge 4 UIRGs in that frontier🔓 One fee unlocks every UIRG under a frontier🧬 Illustrated: graphical abstract published
PathFieldCategoryFrontierUIRGPhD assistance services
CAR-T Cell Engineering and Optimization
10 frontiers
10+
UIRGS
Development of enhanced chimeric antigen receptor T cells with improved specificity, persistence, and reduced off-target toxicity for hematologic malignancies.
RESEARCH GAP FRONTIERS
Combinatorial Antigen Recognition in Multi-Specific CAR-T DesignsMetabolic Reprogramming for Extended CAR-T PersistenceOvercoming Immunosuppressive Microenvironments in Solid Tumors+7 more frontiers
🔓 UIRG access from £41
Explore frontiers →
Clonal Hematopoiesis and Aging Mechanisms
10 frontiers
10+
UIRGS
Investigation of age-related clonal expansion in hematopoietic stem cells and its contribution to cardiovascular disease and leukemic transformation.
RESEARCH GAP FRONTIERS
Clonal Dominance Dynamics in Aging Bone Marrow NichesDNMT3A Mutations and Epigenetic Drift in Hematopoietic Stem CellsInflammaging and Clonal Selection at the Hematopoietic Interface+7 more frontiers
🔓 UIRG access from £41
Explore frontiers →
Thrombotic Microangiopathy Pathophysiology
10 frontiers
10+
UIRGS
Elucidation of complement-mediated mechanisms in hemolytic uremic syndrome and thrombotic thrombocytopenic purpura with novel therapeutic interventions.
RESEARCH GAP FRONTIERS
Complement-Driven Endothelial Injury in Thrombotic MicroangiopathyADAMTS13 Dysfunction and Ultralarge Von Willebrand Factor DynamicsPlatelet Activation Cascades in Microvascular Thrombosis+7 more frontiers
🔓 UIRG access from £41
Explore frontiers →
Iron Metabolism and Ferroptosis in Erythrocytes
10 frontiers
10+
UIRGS
Study of iron-dependent cell death pathways in red blood cells and their implications for anemia and transfusion-related complications.
RESEARCH GAP FRONTIERS
Iron-Sulfur Clusters and Erythrocyte Metabolic ResilienceFerroptotic Vulnerabilities in Hemoglobin-Iron DynamicsFerritinophagy and Red Cell Lifespan Regulation+7 more frontiers
🔓 UIRG access from £41
Explore frontiers →
Gene Therapy for Inherited Blood Disorders
10 frontiers
10+
UIRGS
Development and clinical translation of lentiviral and adeno-associated viral vectors for sickle cell disease and beta-thalassemia correction.
RESEARCH GAP FRONTIERS
Off-Target Integration and Clonal Dominance in HSC Gene TherapyImmune Recognition of Gene-Corrected Blood CellsEpigenetic Silencing of Therapeutic Transgenes in Hematopoiesis+7 more frontiers
🔓 UIRG access from £41
Explore frontiers →
Megakaryopoiesis and Platelet Biogenesis
10 frontiers
10+
UIRGS
Molecular mechanisms governing megakaryocyte maturation, proplatelet formation, and production of functional platelets from bone marrow stem cells.
RESEARCH GAP FRONTIERS
Cytoskeletal Dynamics in Megakaryocyte PolyploidizationProplatelet Formation and Mechanotransduction at the MembraneTranscriptional Reprogramming During Megakaryocyte Maturation+7 more frontiers
🔓 UIRG access from £41
Explore frontiers →
Immunothrombosis and Neutrophil Extracellular Traps
10 frontiers
10+
UIRGS
Investigation of NETs in bacterial infections, autoimmune diseases, and their pathogenic role in disseminated intravascular coagulation.
RESEARCH GAP FRONTIERS
Neutrophil Extracellular Traps in Thromboinflammatory DiseaseNETosis-Driven Coagulation Amplification at Vascular BarriersHistone-Mediated Immunothrombosis in Sepsis and Trauma+7 more frontiers
🔓 UIRG access from £41
Explore frontiers →
Myelodysplastic Syndrome Cytogenetics
10 frontiers
10+
UIRGS
Characterization of recurrent chromosomal abnormalities and their prognostic significance in clonal disorders of hematopoiesis.
RESEARCH GAP FRONTIERS
Clonal Evolution and Cytogenetic Heterogeneity in MDSComplex Karyotypes as Drivers of Leukemic TransformationSubmicroscopic Deletions and Their Prognostic Architecture+7 more frontiers
🔓 UIRG access from £41
Explore frontiers →
Hematopoietic Stem Cell Mobilization
Optimization of mobilization strategies including G-CSF alternatives and CXCR4 antagonists for improved peripheral stem cell collection.
Explore frontiers →
Platelet Refractoriness and Alloimmunization
Mechanisms of immune and non-immune platelet transfusion resistance with strategies to improve platelet survival in transfused patients.
Explore frontiers →
Hemophilia A and B Gene Replacement
Next-generation AAV vectors and non-viral delivery systems for sustained factor VIII and IX expression in hemophilia treatment.
Explore frontiers →
Diffuse Large B-Cell Lymphoma Genomics
Whole-genome sequencing analysis of DLBCL subtypes to identify prognostic markers and predictive biomarkers for rituximab-chemotherapy response.
Explore frontiers →
Vascular Endothelial Growth Factor Signaling
Role of VEGF pathways in angiogenesis within myeloma bone marrow microenvironment and development of anti-angiogenic therapies.
Explore frontiers →
Fanconi Anemia DNA Repair Pathways
Functional characterization of FANC protein complexes in interstrand crosslink repair and cancer predisposition mechanisms.
Explore frontiers →
Chronic Myeloid Leukemia Imatinib Resistance
Molecular mechanisms of BCR-ABL kinase domain mutations and development of next-generation tyrosine kinase inhibitors for resistant disease.
Explore frontiers →
Von Willebrand Factor Synthesis and Secretion
Regulation of vWF processing in endothelial cells and mechanisms underlying von Willebrand disease with therapeutic implications.
Explore frontiers →
Sickle Cell Disease Vaso-occlusive Crisis
Pathophysiology of hemoglobin S polymerization, endothelial dysfunction, and inflammatory cascades triggering acute vaso-occlusive events.
Explore frontiers →
Acute Promyelocytic Leukemia Differentiation Therapy
Mechanisms of all-trans retinoic acid and arsenic trioxide in PML-RARA fusion protein degradation and leukemic cell differentiation.
Explore frontiers →
MicroRNA Regulation in Erythropoiesis
Discovery of miRNA signatures controlling red blood cell development, hemoglobin switching, and erythroid differentiation from progenitors.
Explore frontiers →
Lymphoid Progenitor Cell Specification
Transcriptional networks governing B and T cell lineage commitment from common lymphoid progenitors in bone marrow and thymus.
Explore frontiers →
Coagulation Factor V Leiden Thrombophilia
Genetic and phenotypic characterization of factor V Leiden mutation impact on protein C resistance and venous thromboembolism risk.
Explore frontiers →
B-Cell Receptor Signaling in Lymphoma
Chronic active BCR signaling in lymphoid malignancies and therapeutic targeting of downstream kinases including BTK and SYK.
Explore frontiers →
Hemoglobin H Disease and Alpha-Globin
Molecular basis of alpha-thalassemia trait phenotypes and development of therapeutic strategies for alpha-globin chain imbalance.
Explore frontiers →
Immune-Mediated Thrombocytopenia Pathogenesis
Characterization of antiplatelet antibodies, complement activation, and cellular immune mechanisms in immune thrombocytopenia.
Explore frontiers →
Transthyretin Amyloid Fibril Formation
Mechanisms of hereditary amyloidosis in hematologic systems and development of stabilizers preventing transthyretin misfolding.
Explore frontiers →
Monocyte Subset Differentiation and Function
Classification and ontogeny of classical, intermediate, and non-classical monocyte populations in health and hematologic disease.
Explore frontiers →
Polycythemia Vera JAK2 Mutation Biology
Molecular consequences of JAK2 V617F mutation in myeloproliferative neoplasms with focus on thromboembolic complications.
Explore frontiers →
Dendritic Cell Immunotherapy Development
Generation and antigen-loading strategies of dendritic cells for cancer vaccines in hematologic and solid malignancies.
Explore frontiers →
Prothrombin G20210A Polymorphism Thrombosis
Functional characterization of prothrombin variant impact on factor II levels and venous thromboembolism susceptibility.
Explore frontiers →
Hodgkin Lymphoma Microenvironment Cellular Composition
Role of T cells, macrophages, and immune checkpoints in Hodgkin lymphoma pathogenesis and resistance to immunotherapy.
Explore frontiers →
Hypogammaglobulinemia and B-Cell Dysfunction
Mechanisms of common variable immunodeficiency including class switch recombination failure and impaired antibody production.
Explore frontiers →
Protein C and S Pathway Anticoagulation
Regulation of factors Va and VIIIa by activated protein C and its implications in thrombotic disorders.
Explore frontiers →
Follicular Lymphoma Transformation Mechanisms
Genomic alterations and microenvironmental factors driving transformation to aggressive diffuse large B-cell lymphoma.
Explore frontiers →
Thrombopoietin Receptor Agonist Resistance
Mechanisms of platelet response failure to TPO mimetics in immune thrombocytopenia and establishment of predictive biomarkers.
Explore frontiers →
Hemolytic Disease of the Newborn Prevention
Immunologic basis of maternal-fetal blood group incompatibility and optimization of RhIG prophylaxis strategies.
Explore frontiers →
Atypical Hemolytic Uremic Syndrome Complement
Mutations in complement regulatory genes and C3 dysregulation in aHUS pathogenesis with eculizumab resistance mechanisms.
Explore frontiers →
Natural Killer Cell Receptor Signaling
KIR and NKG2D pathway interactions in viral infection control and exploitation by hematologic malignancies for immune evasion.
Explore frontiers →
Paroxysmal Nocturnal Hemoglobinuria Etiopathology
PIGA gene mutations, acquired hematopoietic stem cell clones, and complement-mediated hemolysis mechanisms in PNH.
Explore frontiers →
Mantle Cell Lymphoma Cyclin D1 Overexpression
Role of t(11;14) translocation in cell cycle dysregulation and therapeutic targeting of CDK4/6 pathways.
Explore frontiers →
Erythropoietin Receptor Signaling Pathways
JAK2-STAT5 and PI3K-AKT cascades in erythroid progenitor proliferation and their dysregulation in polycythemia vera.
Explore frontiers →
Antiphospholipid Syndrome Thrombosis Mechanism
Beta-2 glycoprotein I antibody-mediated tissue factor activation and complement-driven thromboinflammation in APS.
Explore frontiers →
Acute Myeloid Leukemia NPM1 Mutations
Nucleophosmin alterations affecting leukemic stem cell self-renewal and predictive value for AML prognosis and treatment response.
Explore frontiers →
Marginal Zone Lymphoma Lymphocyte Homing
Chemokine receptor expression patterns directing malignant B cells to splenic, nodal, and extranodal marginal zone compartments.
Explore frontiers →
Red Blood Cell Membrane Protein Interactions
Spectrin-actin cytoskeleton assembly and band 3 protein complexes in maintaining RBC deformability and preventing hemolysis.
Explore frontiers →
Burkitt Lymphoma MYC Translocation Biology
Mechanisms of t(8;14) translocation, MYC oncogene deregulation, and selective vulnerability to cell cycle checkpoint inhibitors.
Explore frontiers →
Disseminated Intravascular Coagulation Biomarkers
Tissue factor pathway activation, thrombin generation, and fibrinogen consumption as predictive markers in DIC pathophysiology.
Explore frontiers →
Hereditary Spherocytosis Ion Channel Defects
Mutations in band 3, spectrin, and protein 4.2 causing osmotic fragility and increased RBC destruction mechanisms.
Explore frontiers →
Multiple Myeloma Proteasome Inhibitor Resistance
Molecular mechanisms of bortezomib and carfilzomib resistance including altered proteasomal subunits and KRAS mutations.
Explore frontiers →
Lymphatic Endothelial Cell Development
PROX1 and VEGFR3 signaling in lymphatic vessel formation and its role in immune cell trafficking and lymphoma dissemination.
Explore frontiers →
Congenital Afibrinogenemia Fibrin Assembly
FGA, FGB, and FGG gene mutations preventing fibrinogen synthesis and pathophysiology of severe bleeding tendency.
Explore frontiers →
Splenic Sequestration and Red Blood Cell Clearance
Investigation of macrophage-mediated erythrocyte phagocytosis and mechanisms of pathological splenic retention in hemolytic anemias.
Explore frontiers →
Neutrophil Chemotaxis and Migration Dynamics
Study of chemoattractant gradients and intracellular signaling pathways governing neutrophil recruitment to inflammatory sites.
Explore frontiers →
Tissue Factor Pathway Inhibitor Regulation
Examination of TFPI expression, localization, and anticoagulant function across endothelial and hematopoietic compartments.
Explore frontiers →
Thrombin Generation Assay Standardization
Development of calibrated methods for measuring thrombin kinetics in plasma for coagulation disorder diagnosis.
Explore frontiers →
Basophil Degranulation and Histamine Release
Analysis of IgE-mediated activation mechanisms and mediator secretion in allergic and parasitic responses.
Explore frontiers →
Thalassemia Intermedia Iron Overload Complications
Investigation of secondary hemochromatosis pathophysiology and organ damage in non-transfusion-dependent thalassemia patients.
Explore frontiers →
B-Cell Lymphoma Drug Resistance Mechanisms
Elucidation of genetic and epigenetic alterations conferring chemotherapy and targeted therapy resistance in B-cell malignancies.
Explore frontiers →
Platelet Activation and Thrombus Initiation
Study of P2Y12 and GPVI signaling cascades leading to platelet shape change and aggregation.
Explore frontiers →
Hemoglobin Glycosylation and Diabetes Complications
Investigation of non-enzymatic glycation of hemoglobin and its role in vascular complications in diabetic patients.
Explore frontiers →
Lymphocyte Exhaustion in Chronic Infections
Analysis of PD-1, TIM-3, and LAG-3 expression patterns and functional impairment in persistent viral infections.
Explore frontiers →
Endothelial Glycocalyx Function and Thrombosis
Examination of glycocalyx integrity and its role in anticoagulant surface properties and vascular permeability.
Explore frontiers →
Acute Lymphoblastic Leukemia Minimal Residual Disease
Development of flow cytometry and molecular techniques for detecting leukemic blasts below morphologic detection limits.
Explore frontiers →
Fibrinogen Dysfunction and Dysfibrinogenemia
Study of hereditary and acquired fibrinogen structural variants affecting clot formation and fibrinolysis.
Explore frontiers →
Myeloproliferative Neoplasm Transformation to Acute Leukemia
Investigation of genomic evolution and clonal competition driving progression from chronic to blast phase disease.
Explore frontiers →
Red Blood Cell Lifespan Measurement Techniques
Development of radiolabeling and biotin-based methods for quantifying erythrocyte survival in hemolytic conditions.
Explore frontiers →
T-Cell Acute Lymphoblastic Leukemia Oncogenesis
Analysis of NOTCH1, TAL1, and LYL1 mutations driving T-lineage lymphoblast transformation and proliferation.
Explore frontiers →
Platelet-Derived Microparticles and Thromboinflammation
Investigation of microvesicle generation, tissue factor expression, and pro-inflammatory signaling in vascular disease.
Explore frontiers →
Hemolytic Transfusion Reaction Complement Activation
Study of classical and alternative pathway activation following ABO incompatibility and antibody-mediated red cell destruction.
Explore frontiers →
Hematopoietic Stem Cell Niche Microenvironment
Examination of osteoblast, osteoclast, and vascular cell contributions to HSC quiescence and self-renewal regulation.
Explore frontiers →
Plasma Cell Myeloma Extramedullary Manifestations
Investigation of mechanisms underlying clonal plasma cell migration and proliferation outside bone marrow compartments.
Explore frontiers →
Antithrombin III Conformational Heparin Binding
Study of allosteric mechanisms of heparin-induced conformational change and enhanced serine protease inhibition.
Explore frontiers →
Granulocytic Sarcoma Extramedullary Acute Myeloid Leukemia
Analysis of myeloid blast tissue infiltration patterns and clonal relationships to bone marrow disease in AML.
Explore frontiers →
Platelet Plug Formation and Hemostasis
Integrated study of platelet adhesion, spreading, and bridging mechanisms in primary hemostatic responses.
Explore frontiers →
Lymphoblastoid Cell Line Epstein-Barr Virus Integration
Investigation of viral genome integration sites and their effects on gene expression in transformed B cells.
Explore frontiers →
Hemin-Induced Hemolysis and Oxidative Stress
Study of free heme toxicity, iron catalyzed reactive oxygen species generation, and cellular antioxidant responses.
Explore frontiers →
Chronic Lymphocytic Leukemia Microenvironment Interactions
Analysis of nurselike cell support, T-cell dysfunction, and stromal cell-mediated survival signals in CLL progression.
Explore frontiers →
Factor VIII Inhibitor Development and Bypassing Agents
Investigation of anti-FVIII antibody formation mechanisms and efficacy of prothrombin complex and recombinant therapies.
Explore frontiers →
Monocyte-Derived Macrophage Polarization and Cytokines
Study of M1/M2 phenotype differentiation pathways and cytokine production in inflammation and hematopoietic support.
Explore frontiers →
Warm Autoimmune Hemolytic Anemia IgG Subclass
Characterization of pathogenic autoantibody IgG subtypes and their relationship to C3 complement deposition patterns.
Explore frontiers →
Natural Killer T-Cell Invariant TCR Signaling
Analysis of iNKT cell glycolipid antigen recognition and downstream effector cytokine secretion pathways.
Explore frontiers →
Reticular Dysgenesis Mitochondrial Dysfunction
Investigation of AK2 mutations impairing mitochondrial ATP synthesis and hematopoietic progenitor cell survival.
Explore frontiers →
Platelet Adhesion Molecule Expression and Aging
Study of P-selectin, CD40L, and integrin changes in aging platelets and their thrombotic consequences.
Explore frontiers →
Waldenström Macroglobulinemia MYD88 Mutation Signaling
Elucidation of L265P MYD88 mutation effects on Toll-like receptor signaling and NF-kappa-B pathway activation.
Explore frontiers →
Heparin-Induced Thrombocytopenia Type II Pathophysiology
Study of PF4-heparin complex immunogenicity and platelet activation by PF4-specific IgG antibodies.
Explore frontiers →
Erythropoietic Protoporphyria Iron Metabolism Dysregulation
Investigation of heme synthase deficiency effects on iron utilization and porphyrin accumulation in erythroid cells.
Explore frontiers →
Lymphocyte Homing Receptor and Integrin Expression
Analysis of L-selectin, CCR7, and alpha-4 integrin regulation in lymphocyte trafficking and tissue infiltration.
Explore frontiers →
Alpha-Thalassemia Hydrops Fetalis Pathophysiology
Investigation of severe anemia consequences including cardiac dysfunction and fetal fluid accumulation mechanisms.
Explore frontiers →
Acute Promyelocytic Leukemia Arsenic Trioxide Therapy
Study of arsenic-induced proteasomal degradation of PML-RARA fusion protein and differentiation mechanisms.
Explore frontiers →
Monocyte Tissue Factor Expression and Inflammation
Analysis of LPS and TNF-alpha induced monocyte TF upregulation and coagulation initiation in sepsis.
Explore frontiers →
Hemoglobin S Polymerization and Fiber Formation
Molecular investigation of deoxygenation-induced HbS fiber polymerization and mechanical erythrocyte distortion.
Explore frontiers →
Systemic Mastocytosis KIT Mutation Mast Cell Proliferation
Study of D816V KIT mutations driving constitutive signaling and uncontrolled mast cell accumulation.
Explore frontiers →
Platelet Plug Stability and Fibrinolytic Resistance
Investigation of platelet-fibrin interactions and thrombin-activatable fibrinolysis inhibitor role in clot preservation.
Explore frontiers →
Eosinophilia and Charcot-Leyden Crystal Formation
Study of eosinophil granule protein release and galectin-10 crystallization in parasitic and allergic disease.
Explore frontiers →
Primary Myelofibrosis Megakaryocyte Dysfunction and Fibrosis
Investigation of abnormal megakaryocyte morphology and TGF-beta driven bone marrow fibroblast activation.
Explore frontiers →
Antiphospholipid Antibody Beta-2 Glycoprotein Binding
Analysis of pathogenic anti-beta-2 glycoprotein-I antibody binding and complement-mediated endothelial activation.
Explore frontiers →
Leukotriene-Mediated Eosinophil Recruitment and Activation
Study of eotaxin, RANTES, and leukotriene signaling pathways driving eosinophil extravasation and degranulation.
Explore frontiers →
Immune Thrombotic Thrombocytopenic Purpura ADAMTS13 Deficiency
Investigation of anti-ADAMTS13 autoantibody formation and consequences of VWF-cleaving protease deficiency.
Explore frontiers →
Hairy Cell Leukemia BRAF V600E Mutation Biology
Analysis of oncogenic BRAF signaling in B-cell differentiation arrest and abnormal dendritic cell interactions.
Explore frontiers →
Platelet Membrane Glycoprotein Deficiency Bleeding Disorders
Study of Glanzmann thrombasthenia, Bernard-Soulier syndrome, and other inherited platelet receptor defects.
Explore frontiers →
Methemoglobin Reduction and Cytochrome b5 Reductase
Investigation of NADH-dependent electron transfer pathways maintaining functional hemoglobin iron oxidation state.
Explore frontiers →
Splenic Sequestration and Red Blood Cell Destruction
Investigation of mechanisms by which the spleen recognizes and eliminates aging or antibody-coated erythrocytes through macrophage-mediated phagocytosis and hemolysis.
Explore frontiers →
Neutrophil Granule Protein Secretion Dynamics
Analysis of the temporal and spatial release of azurophil, specific, and gelatinase granule contents during neutrophil activation and degranulation.
Explore frontiers →
Thrombospondin Receptor Interactions in Hemostasis
Exploration of thrombospondin binding to CD36 and other receptors on platelets and endothelial cells in regulating vascular homeostasis.
Explore frontiers →
Lymphocyte Homing Receptor Expression Modulation
Investigation of how L-selectin and integrin expression on T and B cells is dynamically regulated during immune response development.
Explore frontiers →
Hemoglobin Glycation and Diabetic Complications
Study of non-enzymatic glycation of hemoglobin and other blood proteins leading to advanced glycation end-products in diabetes mellitus.
Explore frontiers →
Thrombin Generation Assay Optimization
Development and standardization of calibrated automated thrombography for personalized assessment of individual coagulation potential.
Explore frontiers →
Basophil Activation and Degranulation Pathways
Characterization of IgE-mediated and complement-dependent basophil activation mechanisms and their role in allergic and inflammatory responses.
Explore frontiers →
Platelet Extracellular Vesicle Biogenesis
Analysis of formation, composition, and release of platelet microparticles and exosomes during hemostatic and thrombotic processes.
Explore frontiers →
Megakaryocyte Ploidy and Endomitosis Regulation
Molecular investigation of how megakaryocytes achieve polyploidy through endoreduplication cycles independent of cytokinesis.
Explore frontiers →
Selectin-Ligand Binding in Leukocyte Rolling
Study of P-, E-, and L-selectin interactions with sialyl-Lewis antigens and other carbohydrate ligands mediating initial leukocyte adhesion.
Explore frontiers →
Glucose-6-Phosphate Dehydrogenase Deficiency Variants
Classification and functional characterization of G6PD genetic variants determining hemolytic crisis severity and antimalarial drug susceptibility.
Explore frontiers →
Fibrinogen Structure and Functional Consequences
Analysis of fibrinogen alpha-chain variants and their effects on polymerization kinetics, clot structure, and thrombotic outcomes.
Explore frontiers →
Regulatory T Cell Immunosuppression Mechanisms
Investigation of FOXP3-expressing Treg-mediated suppression through CTLA-4, IL-10, and TGF-beta signaling in lymphoid tissue.
Explore frontiers →
Beta-Thalassemia Hemoglobin Polymerization
Study of polymerization kinetics of hemoglobin S and hemoglobin H in absence of functional beta-globin chains.
Explore frontiers →
Leukocyte Adhesion Deficiency Integrins
Characterization of beta-2 integrin mutations in CD18 deficiency leading to impaired neutrophil recruitment and infections.
Explore frontiers →
Progenitor Cell Niche Microenvironment Signals
Elucidation of stromal cell-derived factor-1, angiopoietin, and Wnt signaling in maintaining hematopoietic stem cell quiescence.
Explore frontiers →
Tissue Plasminogen Activator Fibrin Specificity
Molecular analysis of how tPA achieves selective fibrin-dependent plasminogen activation over free plasminogen in circulation.
Explore frontiers →
Warm Autoimmune Hemolytic Anemia Mechanisms
Investigation of IgG autoantibody production against red blood cell membrane antigens and Fc-receptor mediated erythrophagocytosis.
Explore frontiers →
B-Cell Exhaustion in Chronic Lymphocytic Leukemia
Study of PD-1, TIM-3, and LAG-3 expression on leukemic B cells and their role in evading anti-tumor immunity.
Explore frontiers →
Platelet Adhesion Receptor GPVI Signaling
Characterization of glycoprotein VI collagen receptor signaling and its role in initiating platelet activation and thrombus formation.
Explore frontiers →
Secondary Iron Overload Chelation Therapy
Development and optimization of iron chelators targeting transfusional and ineffective erythropoiesis-driven iron accumulation in organs.
Explore frontiers →
Eosinophil Activation and Granule Protein Release
Study of major basic protein and eosinophil cationic protein release mechanisms in parasitic infection and eosinophilic disorders.
Explore frontiers →
Monocyte Tissue Factor Expression Regulation
Investigation of lipopolysaccharide and oxidized phospholipid-induced tissue factor upregulation on monocyte surface in inflammation.
Explore frontiers →
T-Cell Receptor V-D-J Recombination Clonality
Analysis of T-cell receptor sequence diversity and clonal expansion patterns using high-throughput sequencing in T-cell malignancies.
Explore frontiers →
Antithrombin III Heparin Binding Kinetics
Molecular characterization of how heparin enhances antithrombin inhibition of thrombin and factor Xa through conformational change.
Explore frontiers →
Cold-Agglutinin Disease Complement Activation
Study of IgM antibodies against i-antigen inducing complement-mediated intravascular hemolysis at low temperature.
Explore frontiers →
Neutrophil Elastase Protease Activity Control
Investigation of alpha-1 antitrypsin inhibition of neutrophil elastase and consequences of deficiency in emphysema and vasculitis.
Explore frontiers →
Sphingosine-1-Phosphate Lymphocyte Trafficking
Analysis of S1P1 receptor signaling on lymphocytes and its role in egress from thymus and lymph node compartments.
Explore frontiers →
Primary Immune Thrombocytopenia Autoimmune Tolerance
Study of anti-platelet antibody production and loss of regulatory T cell function in ITP pathogenesis.
Explore frontiers →
Complement Component C3 Convertase Formation
Molecular analysis of how classical, alternative, and lectin pathways generate C3 convertase initiating complement cascade.
Explore frontiers →
Acute Myeloid Leukemia FLT3 Mutation Signaling
Characterization of FLT3-ITD and FLT3-TKD mutations causing constitutive kinase activation in acute myeloid leukemia.
Explore frontiers →
Integrin Alpha-IIb-Beta-3 Bidirectional Signaling
Investigation of inside-out and outside-in signaling through GPIIb/IIIa integrin in platelet activation and aggregation.
Explore frontiers →
Hereditary Persistence Fetal Hemoglobin
Study of gamma-globin gene silencing mechanisms and mutations preventing fetal hemoglobin downregulation in adults.
Explore frontiers →
Myeloperoxidase and Oxidative Burst Dysfunction
Analysis of neutrophil myeloperoxidase deficiency and effects on antimicrobial reactive oxygen species production.
Explore frontiers →
Promyelocytic Leukemia Protein Sumoylation
Investigation of PML nuclear body formation and how arsenic trioxide-induced sumoylation drives leukemic cell degradation.
Explore frontiers →
Vincristine-Induced Peripheral Neuropathy Mechanisms
Study of how vinca alkaloid chemotherapy causes microtubule disruption and neurotoxicity in hematologic malignancy treatment.
Explore frontiers →
Transfusion-Related Acute Lung Injury Prevention
Investigation of HLA and human neutrophil antigen alloimmunization triggering neutrophil activation and pulmonary edema.
Explore frontiers →
Adenosine Deaminase Deficiency Lymphocyte Toxicity
Study of toxic deoxyadenosine metabolite accumulation causing lymphocyte apoptosis in adenosine deaminase deficiency.
Explore frontiers →
Purine Nucleoside Phosphorylase Deficiency T Cells
Analysis of inosine and deoxyinosine accumulation toxicity predominantly affecting T-cell development in PNP deficiency.
Explore frontiers →
Chronic Granulomatous Disease NADPH Oxidase
Characterization of NADPH oxidase complex mutations preventing superoxide generation and bacterial killing in CGD.
Explore frontiers →
Steroid-Resistant Immune Thrombocytopenia Mechanisms
Investigation of molecular mechanisms underlying glucocorticoid insensitivity and persistence of anti-platelet immunity.
Explore frontiers →
Evans Syndrome Autoimmune Hemolytic Anemia Plus
Study of combined autoimmune destruction of red blood cells and platelets through distinct pathogenic antibodies.
Explore frontiers →
Rituximab B-Cell Depletion Pharmacodynamics
Analysis of anti-CD20 monoclonal antibody-mediated B-cell depletion kinetics and immune reconstitution patterns.
Explore frontiers →
Thrombopoietin Megakaryocyte Maturation
Study of TPO receptor signaling in driving megakaryocyte polyploidization and proplatelet formation processes.
Explore frontiers →
Transthyretin Cardiac Amyloidosis Deposition
Investigation of wild-type and mutant transthyretin fibril formation in cardiac tissue causing restrictive cardiomyopathy.
Explore frontiers →
Lymphoma Follicular Helper T Cell Collaboration
Study of how follicular helper T cells provide survival signals to B-cell lymphoma cells through ICOS-ICOSL interaction.
Explore frontiers →
Immune Checkpoint Blockade Lymphoma Resistance
Analysis of mechanisms by which lymphomas evade anti-PD-1 therapy through PD-L1 upregulation and T-cell exhaustion.
Explore frontiers →
Hereditary Xerocytosis Cation Pump Mutations
Characterization of PIEZO1 and KCNN4 mutations causing red blood cell dehydration and osmotic fragility.
Explore frontiers →
Neutrophil Extracellular Trap Formation and Resolution
Investigation of mechanisms controlling NET formation, DNase-mediated degradation, and pathological NET accumulation in autoimmune and infectious diseases.
Explore frontiers →
Acute Leukemia Epigenetic Reprogramming
Study of histone modifications, DNA methylation patterns, and chromatin remodeling complexes driving acute leukemia transformation and therapeutic resistance.
Explore frontiers →
Tissue Resident Memory T Cell Development
Examination of transcriptional programs and adhesion molecules enabling long-lived tissue-dwelling T lymphocytes in hematopoietic tissues.
Explore frontiers →
Primary Myelofibrosis Fibrotic Niche Evolution
Analysis of bone marrow stromal cell transformation, collagen deposition, and aberrant osteoclast activity in myelofibrotic progression.
Explore frontiers →
Bitopic Antibody Engineering for Hematologic Malignancies
Development of dual-targeting antibody constructs simultaneously engaging tumor-associated antigens and immune effector cell receptors.
Explore frontiers →
Angiogenesis and Lymphangiogenesis in Lymphoid Neoplasms
Investigation of vascular and lymphatic endothelial growth factor signaling promoting neovascularization within malignant lymphoid microenvironments.
Explore frontiers →
Acquired Thrombotic Thrombocytopenic Purpura ADAMTS13 Autoimmunity
Study of anti-ADAMTS13 antibody generation, complement activation, and endothelial damage mechanisms in autoimmune thrombotic thrombocytopenic purpura.
Explore frontiers →
Hairy Cell Leukemia BRAF Inhibitor Sensitivity
Mechanistic analysis of BRAF V600E-driven oncogenesis and response to vemurafenib in rare hairy cell leukemia cases.
Explore frontiers →
Platelet-Derived Extracellular Vesicles and Thrombotic Disease
Characterization of microparticle generation, tissue factor transfer, and procoagulant activity in arterial and venous thrombosis.
Explore frontiers →
Splenic Marginal Zone Architecture and Immune Trafficking
Analysis of marginal zone B cell retention, stromal cell organization, and lymphocyte recruitment patterns in splenic immune responses.
Explore frontiers →
Hereditary Persistence Fetal Hemoglobin Silencing
Investigation of BCL11A, KLF1, and epigenetic mechanisms governing gamma-globin gene silencing and therapeutic reactivation strategies.
Explore frontiers →
Immune Checkpoint Molecule Expression Hodgkin Lymphoma
Examination of PD-L1, PD-L2, and PD-1 expression patterns on Hodgkin lymphoma cells and infiltrating immune subsets.
Explore frontiers →
Systemic Mastocytosis KIT Mutation Clonal Burden
Analysis of D816V and other KIT mutations, clonal expansion dynamics, and organopathic mast cell infiltration in systemic mastocytosis.
Explore frontiers →
Red Blood Cell Sickling and Polymerization Kinetics
Molecular dynamics simulation and experimental study of hemoglobin S polymerization rates, fiber stability, and heterozygote protection mechanisms.
Explore frontiers →
B-Cell Maturation Antigen CAR-T Manufacturing Scale-Up
Engineering and optimization of BCMA-directed CAR-T cell production platforms ensuring quality, consistency, and therapeutic efficacy.
Explore frontiers →
Lymphoblastic Leukemia Minimal Residual Disease Stratification
Development of sensitive flow cytometry, PCR, and next-generation sequencing methodologies for prognostic minimal residual disease detection.
Explore frontiers →
Platelet Activation and Aggregation Signal Transduction
Study of P2Y12, GPVI, and thrombin receptor signaling pathways controlling platelet shape change, granule secretion, and hemostatic plug formation.
Explore frontiers →
Hemophilic Arthropathy Synovial Inflammation Prevention
Investigation of iron-driven oxidative stress, macrophage activation, and synovial tissue degeneration in hemophilia-associated joint disease.
Explore frontiers →
Waldenström Macroglobulinemia MYD88 L265P Signaling
Analysis of mutant MYD88-mediated NF-kappa-B activation, Toll-like receptor signaling, and B-cell receptor cooperativity in lymphoplasmacytic lymphoma.
Explore frontiers →
Hematopoietic Stem Cell Long-Term Repopulating Capacity
Investigation of dormancy maintenance, quiescence-exit decisions, and molecular markers predicting sustained self-renewal and multilineage output.
Explore frontiers →
Transfusion-Related Acute Lung Injury Immunopathogenesis
Study of human leukocyte antigen and human neutrophil antigen alloimmunization, neutrophil priming, and pulmonary endothelial activation mechanisms.
Explore frontiers →
Bispecific Antibody Redirected T Cell Cytotoxicity
Engineering of dual-variable domain immunoglobulins and bispecific T-cell engagers for enhanced hematologic malignancy targeting.
Explore frontiers →
Essential Thrombocythemia JAK2 CALR MPL Mutational Hierarchy
Characterization of driver mutation acquisition order, clonal evolution dynamics, and mutation-specific thrombotic risk stratification.
Explore frontiers →
Neonatal Immune Thrombocytopenia Alloimmunization Risk
Investigation of human platelet antigen sensitization mechanisms, maternal antibody transplacental transfer, and neonatal platelet destruction.
Explore frontiers →
Angioimmunoblastic T-Cell Lymphoma TFH Differentiation
Study of follicular helper T-cell transformation, ICOS and PD-1 expression, and B-cell-T-cell cooperativity in peripheral T-cell lymphoma.
Explore frontiers →
Immune Reconstitution After Allogeneic Stem Cell Transplantation
Analysis of thymic output, T-cell and B-cell repertoire recovery, and innate immune restoration kinetics post-hematopoietic transplantation.
Explore frontiers →
Delta-Like Ligand 4 Notch Signaling Hematopoiesis
Investigation of niche cell-derived DLL4-mediated Notch activation controlling hematopoietic stem cell expansion and differentiation.
Explore frontiers →
Warm Autoimmune Hemolytic Anemia Epitope Spreading
Study of anti-red blood cell IgG epitope recognition, B-cell and T-cell collaboration, and loss of immune tolerance mechanisms.
Explore frontiers →
Richter Syndrome Transformation and Clonal Evolution
Investigation of chronic lymphocytic leukemia to diffuse large B-cell lymphoma transformation, TP53 mutation acquisition, and prognostic biomarkers.
Explore frontiers →
Extramedullary Hematopoiesis Splenomegaly Megakaryocyte Sequestration
Analysis of splenic erythropoiesis, megakaryocyte infiltration, and platelet consumption in splenomegaly-associated myeloproliferative disorders.
Explore frontiers →
Neutrophil Gelatinase-Associated Lipocalin Acute Leukemia
Investigation of NGAL as prognostic biomarker, immune activation indicator, and therapeutic target in acute myeloid and lymphoblastic leukemias.
Explore frontiers →
Tissue Factor Pathway Inhibitor and Coagulation Balance
Study of TFPI regulation, factor Xa and IIa inhibition, and therapeutic TFPI augmentation in thrombotic and bleeding disorders.
Explore frontiers →
Nodal Marginal Zone Lymphoma MYD88 NOTCH Mutations
Analysis of simultaneous MYD88 and NOTCH pathway mutations, clonal cooperativity, and lymphomagenesis in nodal marginal zone lymphoma.
Explore frontiers →
Glycoprotein VI and Collagen-Induced Platelet Activation
Mechanistic investigation of GPVI signaling cascades, Syk activation, LAT adaptor function, and collagen response amplification.
Explore frontiers →
Congenital Amegakaryocytic Thrombocytopenia MPL Mutations
Study of thrombopoietin receptor loss-of-function mutations, megakaryopoiesis impairment, and hematopoietic stem cell exhaustion.
Explore frontiers →
Hematopoietic Progenitor Quiescence and Dormancy Regulation
Investigation of cell cycle checkpoint control, hypoxia signaling, and metabolic suppression maintaining long-term hematopoietic progenitor quiescence.
Explore frontiers →
Extranodal Marginal Zone Lymphoma Mucosa-Associated Lymphoid Tissue
Analysis of antigen-driven lymphoma development, pathogen-associated lymphomas, and tissue-homing molecule expression in MALT lymphomas.
Explore frontiers →
Platelet Glycoprotein Polymorphisms and Thrombotic Risk
Investigation of GPIIb-IIIa, GPIa-IIa, and ABO blood group polymorphisms predicting individual thrombotic susceptibility and bleeding phenotypes.
Explore frontiers →
Tumor Necrosis Factor-Alpha Signaling Hematologic Malignancy
Study of TNF-alpha-driven inflammation, NF-kappa-B activation, and immunotherapy resistance in lymphomas and myeloid malignancies.
Explore frontiers →
Immunoglobulin Variable Region Gene Rearrangement and Selection
Analysis of V(D)J recombination, somatic hypermutation mechanisms, and antigen selection driving lymphoid malignancy development.
Explore frontiers →
Hemophilia B Factor IX Gene Therapy Durability
Investigation of adeno-associated viral vector transduction efficiency, hepatocyte integration stability, and long-term factor IX expression.
Explore frontiers →
Megakaryocyte Endomitosis and Polyploidy Generation
Study of unique cytoplasmic mitosis, DNA replication without cytokinesis, and polyploid nuclear formation driving megakaryocyte maturation.
Explore frontiers →
Lymphomas Associated BRAF and MAP2K1 Mutations
Investigation of BRAF V600E and MEK1/2 mutations in Hodgkin and non-Hodgkin lymphomas, targeted therapy response and resistance.
Explore frontiers →
Heparin-Induced Thrombocytopenia Platelet Activating Antibodies
Study of anti-PF4-heparin IgG antibody generation, platelet activation complex formation, and immune-mediated thrombosis mechanisms.
Explore frontiers →
Monocyte Lineage Specification and Osteoclast Differentiation
Investigation of M-CSF and RANKL signaling, NF-kappa-B and NFAT transcription factors, and bone-resorbing osteoclast development.
Explore frontiers →
Primary Central Nervous System Lymphoma Pathobiology
Analysis of blood-brain barrier disruption, cerebral immune privilege evasion, and B-cell lymphoma trafficking to the central nervous system.
Explore frontiers →
Germinal Center B Cell Development and Selection
Investigation of activation-induced cytidine deaminase function, somatic hypermutation patterns, and selection signals in follicular B-cell lymphomas.
Explore frontiers →
Hereditary Elliptocytosis Spectrin Dimer Defects
Study of alpha- and beta-spectrin mutations, red blood cell membrane skeletal protein interactions, and osmotic fragility alterations.
Explore frontiers →
Natural Killer Cell Education and Missing Self Recognition
Investigation of human leukocyte antigen-C and killer immunoglobulin-like receptor interactions, NK cell licensing, and tumor immune surveillance.
Explore frontiers →
Lymphoid Progenitor Self-Renewal and Differentiation Balance
Study of transcription factor networks controlling common lymphoid progenitor expansion versus B-cell or T-cell lineage commitment.
Explore frontiers →
Tissue Factor Pathway Inhibitor Regulation in Sepsis
Elucidation of TFPI modulation during systemic inflammation and sepsis-induced coagulopathy to identify therapeutic targets for disseminated intravascular coagulation prevention.
Explore frontiers →
Neutrophil Extracellular Trap Formation and Resolution
This research investigates the molecular mechanisms governing NET formation, degradation pathways, and their dysregulation in inflammatory and thrombotic hematologic disorders.
Explore frontiers →